Research Conducted at Regeneron Pharmaceuticals Inc. Has Provided New Information about COVID-19 (Efficacy and Safety of a Single Dose of Casirivimab and Imdevimab for the Prevention of Covid-19 Over an 8-month Period: a Randomised, ...)

  • Meagan P. O'Brien

Press/Media

Period1 Feb 2023

Media coverage

1

Media coverage

  • TitleResearch Conducted at Regeneron Pharmaceuticals Inc. Has Provided New Information about COVID-19 (Efficacy and Safety of a Single Dose of Casirivimab and Imdevimab for the Prevention of Covid-19 Over an 8-month Period: a Randomised, ...)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date1/02/23
    PersonsMeagan P. O'Brien